Endex 19.5 % w/v Oral Suspension for Cattle
Endex 19.5 % w/v Oral Suspension for Cattle
Not authorised
- Levamisole hydrochloride
- Triclabendazole
Product identification
Medicine name:
Endex 19.5 % w/v Oral Suspension for Cattle
Active substance:
- Levamisole hydrochloride
- Triclabendazole
Target species:
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Levamisole hydrochloride7.50/gram(s)100.00millilitre(s)
-
Triclabendazole12.00/gram(s)100.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Cattle
-
Meat and offal46day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC30
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Ireland
Package description:
- 12 litre HDPE containers with screw cap lids containing white to off-white aqueous suspension.
- 2.2 litre HDPE containers with screw cap lids containing white to off-white aqueous suspension.
- 0.8 litre HDPE containers with screw cap lids containing white to off-white aqueous suspension.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S.
- Argenta Dundee Limited
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA22020/035/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?:
